VivoSim Labs
Open
$1.16
Prev. Close
$1.16
High
$1.16
Low
$1.16
Market Snapshot
$2.97M
-2.4
-10.25
$122K
14
VivoSim Labs, Inc. is engaged in the development of bioprinted human tissues that emulate human biology and disease. The company is headquartered in San Diego, California and currently employs 13 full-time employees. The company went IPO on 2013-08-02. The firm offers partners liver and intestinal toxicology insights using its new approach methodologies (NAM) models. The firm offers liver toxicology predictive screening and research services as well as working on predicting and studying the intestinal side effect profiles of drugs that are therapeutic candidates of pharmaceutical and biotech companies at all stages of drug development. The company uses its proprietary technologies to build functional 3D human tissues that mimic key aspects of native human tissue composition, architecture, function, and disease. The firm also advances product candidates to treat inflammatory bowel disease (IBD) discovered and developed using its complex human tissue intestinal models.
VivoSim Labs, Inc. is engaged in the development of bioprinted human tissues that emulate human biology and disease. The company is headquartered in San Diego, California and currently employs 13 full-time employees. The company went IPO on 2013-08-02. The firm offers partners liver and intestinal toxicology insights using its new approach methodologies (NAM) models. The firm offers liver toxicology predictive screening and research services as well as working on predicting and studying the intestinal side effect profiles of drugs that are therapeutic candidates of pharmaceutical and biotech companies at all stages of drug development. The company uses its proprietary technologies to build functional 3D human tissues that mimic key aspects of native human tissue composition, architecture, function, and disease. The firm also advances product candidates to treat inflammatory bowel disease (IBD) discovered and developed using its complex human tissue intestinal models.
Recently from Cashu
No content provided for summarization. Please share the text you'd like me to summarize.
It seems that you haven’t provided any specific content to summarize. Please paste the text you want me to work with, and I can assist you in creating the summary. To answer your initial questions: -…
VivoSim Labs: Key Developments and Future Outlook for Investors
Sure! Please provide the text you would like me to summarize, and I'll create a 300-word paragraph for you.
VivoSim Labs: Innovating Biotechnology with Advanced Simulation for Efficient Drug Development
VivoSim Labs: Pioneering Technological Innovation in Biotechnology VivoSim Labs stands at the forefront of the biotechnology industry, focusing on integrating advanced simulation technologies to enhan…
VivoSim Labs: Innovative Solutions for Enhanced Virtual Simulation Technology.
Please provide the content you would like summarized into a 300-word paragraph, and I'll be happy to assist you!